• HOME
  • ABOUT
    • EXECUTIVE SUMMARY
    • MANAGEMENT TEAM
    • SCIENTIFIC ADVISORY BOARD
    • R&D PARTNER
  • RESEARCH
    • CELL TECHNOLOGY
    • THE SCIENCE
    • MICROENCAPSULATION
  • GLOBAL
    • ALTUCELL BACKGROUND
    • MARKET OPPORTUNITY
    • INTELLECTUAL PROPERTY
  • BROAD VIEW
    • DIABETES
    • AUTOIMMUNE DISEASES
  • PROFILE
    • PRODUCT APPLICATIONS
    • INVESTMENT HIGHLIGHTS
    • COMPANY MILESTONES
  • PUBLICATIONS
  • CONTACT
  • More
    • HOME
    • ABOUT
      • EXECUTIVE SUMMARY
      • MANAGEMENT TEAM
      • SCIENTIFIC ADVISORY BOARD
      • R&D PARTNER
    • RESEARCH
      • CELL TECHNOLOGY
      • THE SCIENCE
      • MICROENCAPSULATION
    • GLOBAL
      • ALTUCELL BACKGROUND
      • MARKET OPPORTUNITY
      • INTELLECTUAL PROPERTY
    • BROAD VIEW
      • DIABETES
      • AUTOIMMUNE DISEASES
    • PROFILE
      • PRODUCT APPLICATIONS
      • INVESTMENT HIGHLIGHTS
      • COMPANY MILESTONES
    • PUBLICATIONS
    • CONTACT
  • HOME
  • ABOUT
    • EXECUTIVE SUMMARY
    • MANAGEMENT TEAM
    • SCIENTIFIC ADVISORY BOARD
    • R&D PARTNER
  • RESEARCH
    • CELL TECHNOLOGY
    • THE SCIENCE
    • MICROENCAPSULATION
  • GLOBAL
    • ALTUCELL BACKGROUND
    • MARKET OPPORTUNITY
    • INTELLECTUAL PROPERTY
  • BROAD VIEW
    • DIABETES
    • AUTOIMMUNE DISEASES
  • PROFILE
    • PRODUCT APPLICATIONS
    • INVESTMENT HIGHLIGHTS
    • COMPANY MILESTONES
  • PUBLICATIONS
  • CONTACT

CELL TECHNOLOGY

Encapsulated Cell Therapy

 A Transformative Approach to Cell-Based Therapeutics

Encapsulated cell therapy represents a cutting-edge frontier in biopharmaceutical innovation, offering the potential to treat serious and chronic diseases without the need for systemic immunosuppression.  ALTuCELL has developed a proprietary platform that combines patented, bioengineered therapeutic cells with a patented encapsulation technology, designed to deliver targeted, immune-protected treatment.  Our advanced cellular platform features key characteristics that support efficacy and scalable manufacturing:


  • High expression of immunoregulatory proteins
  • Excellent viability and stability within the encapsulated environment
  • Controlled and predictable cell division
  • Scalable production for commercial application
  • Use of cell types with established clinical relevance
  • Designed for ease of implantation and retrieval
  • Broad applicability across multiple disease areas


This platform positions ALTuCELL at the forefront of regenerative and cell-based medicine, with the potential to revolutionize therapeutic delivery for a wide range of unmet medical needs.


Copyright © 2018 ALTUCELL - All Rights Reserved


Powered by